A 61-year-old man with type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and albuminuria is being treated with an ACE inhibitor and an SGLT2 inhibitor. He asks about his glycemic target. Which of the following aligns with CKD guidelines?